UNCONDITIONAL GUARANTYUnconditional Guaranty • August 14th, 2013 • Alimera Sciences Inc • Pharmaceutical preparations • New York
This continuing Unconditional Guaranty (“Guaranty”) is entered into as of May 7, 2013, by AS C.V., a limited partnership formed under the laws of the Netherlands (“Guarantor”), in favor of SILICON VALLEY BANK, a California corporation (“Bank”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • August 14th, 2013 • Alimera Sciences Inc • Pharmaceutical preparations • New York
This LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of May 7, 2013 (the “Effective Date”) is between SILICON VALLEY BANK, a California corporation (“Bank”), and ALIMERA SCIENCES LIMITED, a company registered under the laws of England and Wales under company number 08018355 and having its registered office at Garrick House, 26-27 Southampton Street, London, United Kingdom, WC2E 7RS (“Borrower”), and provides the terms on which Bank shall lend to Borrower, and Borrower shall repay Bank. The parties agree as follows:
SECURITY AGREEMENTSecurity Agreement • August 14th, 2013 • Alimera Sciences Inc • Pharmaceutical preparations
This SECURITY AGREEMENT (this “Agreement”) is entered into as of May 7, 2013 (the “Effective Date”), by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 (“Bank”) and ALIMERA SCIENCES, INC., a Delaware corporation, with its chief executive office located at 6120 Windward Parkway, Suite 290, Alpharetta, Georgia 30005 (“Debtor”).
AMENDMENT NO. 1 TO WARRANT TO PURCHASE STOCKWarrant to Purchase Stock • August 14th, 2013 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 1 TO WARRANT TO PURCHASE STOCK (this “Amendment No.1”) is made as of May 7, 2013 by and between SVB Financial Group (“Holder”) and Alimera Sciences, Inc., a Delaware corporation (the “Company”).
SECOND LOAN MODIFICATION AGREEMENT (WORKING CAPITAL LINE OF CREDIT)Loan Modification Agreement • August 14th, 2013 • Alimera Sciences Inc • Pharmaceutical preparations
This Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of May 7, 2013, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and ALIMERA SCIENCES, INC., a Delaware corporation, with its chief executive office located at 6120 Windward Parkway, Suite 290, Alpharetta, Georgia 30005 (“Borrower”).
